CClinicalTrials.gg
Active, not recruitingNCT06982248Updated May 21, 2025

The Proposed Study Aims to Investigate the Efficacy of Quercetin as an Adjunctive to Mechanical Debridement in Treatment of Periodontitis

A Phase 2 interventional study of NSP and chitosan nanoparticles gel loaded by quercetin and NSP and chitosan nanoparticles gel in Periodontal Pocket, sponsored by Mansoura University. Active, not recruiting at 1 site in Egypt. Open to participants aged 25 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-21.

Sponsored by Mansoura University · Phase 2, Interventional, and Treatment

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Aug 2024, registered Dec 2024).
Phase
Phase 2
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
25 Years to 55 Years
Sex
All
01

Study summary

the proposed study aims to investigate the effect of Quercetin in treatment of periodontitis patients

Read the detailed description

the proposed study aims to investigate the effect of Quercetin in treatment of periodontitis patients not having systemic diseases.the 2ry aim of study to estimate the neacular factor kabba B level in gingival crevicular fluids.

02

Conditions studied

  • Periodontal Pocket
03

In context

Periodontitis

1,635 studies on the registry are indexed under Periodontitis; 327 are open to participants now.

This study's planned enrollment of 60 is above the median of 45 across 1,191 interventional studies indexed under Periodontitis.

Browse Periodontitis studies →

Lead sponsor

Mansoura University is the lead sponsor of 1,077 studies on the registry; 183 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Patients of both sexes with an age ranging between 25 and 55 years will be included in the study. Patients diagnosed as having periodontitis based on clinical and radiographic examinations will be included

Exclusion criteria

Exclusion Criteria:

  • Insulin dependent diabetes
  • Thyroid disease
  • Patients with sensitivity to the medication used in the study
  • patients with a history of antibiotic use or anti-inflammatory drugs during the previous 3 months prior to the study will be excluded from the study.
  • Additionally, patients with systemic diseases, smokers, pregnant and lactating patients, and patients not compliant with oral hygiene procedures will also be excluded
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Single (Participant)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Group 1: Periodontitis patients treated by NSPT and chitosan nanoparticles gel loaded by quercetin

    selected patients receive SRP and chitosan nanoparticles gel loaded by quercetin

    Drug: NSP and chitosan nanoparticles gel loaded by quercetin

  • Experimental
    Group 2: Periodontitis patients treated by NSPT and chitosan nanoparticles gel.

    selected patients receive SRP and chitosan nanoparticles gel

    Drug: NSP and chitosan nanoparticles gel

  • Active comparator
    Group 3: Periodontitis patients treated by NSPT only

    NSPT

    Procedure: scaling and root planning

  • No intervention
    Group 4: Periodontally healthy subjects.

    healthy individual act as control group

Interventions

  • DrugNSP and chitosan nanoparticles gel loaded by quercetin

    NSP and chitosan nanoparticles gel loaded by quercetin

  • DrugNSP and chitosan nanoparticles gel

    NSP and chitosan nanoparticles gel

  • Procedurescaling and root planning

    NSPT

06

What researchers measure

Primary outcomes

  1. assessment clinical attachment level by UNC 15 periodontal probe

    Time frame: 12 weeks

Secondary outcomes

  1. assessment of the gingival crevicular levels of NF-κB by Elisa kit

    Time frame: 12 weeks

07

Study locations

1 site
  • Faculty of Dentistry, Mansoura University
    Aga, Egypt
08

References and documents

Individual participant data

Plan to share: Undecided — Clinical effect of Quercetin in treatment of periodiontal pocket

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 21, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06982248
Lead sponsor
Mansoura University
Responsible party
Sponsor
First posted
May 21, 2025
Start date
Aug 15, 2024
Primary completion
Feb 1, 2025
Completion
Jun 1, 2025 (estimated)
Last update
May 21, 2025

Study contacts

Jilan mohamed
study director · Mansoura University

Oversight

Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion